Linsitinib

CAS : 867160-71-2

Ref. TM-T6017

Informations sur le produit

• Nom: Linsitinib
• Synonymes: OSI-906, Cyclobutanol, 3-[8-amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methyl-, cis-, Osi 906Aa, Osi-906
• CAS: 867160-71-2

Description

OSI-906 (Linsitinib (OSI-906)) is an orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitinib selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Overexpressed in a variety of human cancers, IGF-1R stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 421.49
• Formule: C₂₆H₂₃N₅O
• Degré de pureté: 99.8%
• Couleur/Forme: Solid